Advisory Services Network’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$57.6K Buy
+2,326
New +$55.4K ﹤0.01% 2538
2025
Q4
Sell
-2,002
Closed -$39.4K 2306
2025
Q3
$39.4K Buy
+2,002
New +$41.2K ﹤0.01% 2576
2024
Q1
Sell
-500
Closed -$8.4K 1887
2023
Q4
$8.4K Buy
+500
New +$6.83K ﹤0.01% 2934
2023
Q2
Sell
-1,801
Closed -$29.9K 1889
2023
Q1
$29.9K Buy
1,801
+1,301
+260% +$21.5K ﹤0.01% 2305
2022
Q4
$9.3K Buy
+500
New +$7.7K ﹤0.01% 2890
2020
Q4
Sell
-400
Closed -$1K 3365
2020
Q3
$1K Buy
+400
New +$1.56K ﹤0.01% 3291

Other funds holding CPRX

Advisory Services Network's CPRX Position: Q1 2026 in Review

Advisory Services Network opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 2,326 shares worth $57.6K. The stake represents ﹤0.01% of the portfolio and ranks #2538 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CPRX as recently as Q3 2025.

Advisory Services Network first reported a position in CPRX in Q3 2020 and has held it in 6 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Advisory Services Network held 2,326 shares of Catalyst Pharmaceutical worth $57.6K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Advisory Services Network position in Q1 2026.
  • Catalyst Pharmaceutical made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #2538 holding.
  • Advisory Services Network first reported a position in Catalyst Pharmaceutical in Q3 2020 and has held it in 6 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.